Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Weikel, W

Lymphonodektomie beim Vulvakarzinom: Wann und wie vorgehen?

Frauenheilkunde up2date. Bd. 13. H. 4. 2019 S. 355-365


Moehler, Markus; Ryu, Min-Hee; Dvorkin, Mikhail et al.

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design

FUTURE ONCOLOGY. Bd. 15. H. 6. 2019 S. 567-577



Ruecker, Frank G.; Agrawal, Mridul; Corbacioglu, Andrea et al.

Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

BLOOD. Bd. 134. H. 19. 2019 S. 1608-1618


Schlenk, Richard F.; Weber, Daniela; Fiedler, Walter et al.

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

BLOOD. Bd. 133. H. 8. 2019 S. 840-851


Ahmed, Shakil; Chowdhury, Ezharul Hoque; Zimmermann, Tim et al.

MOLECULAR ENDOSCOPIC IMAGING FOR TARGETED VISUALIZATION OF CELL ADHESION MOLECULES IN PATIENTS WITH LIVER CIRRHOSIS

GASTROINTESTINAL ENDOSCOPY. Bd. 89. H. 6. 2019 S. AB634-AB635


Ahmed, Shakil; Galle, Peter R.; Neumann, Helmut

Molecular endoscopic imaging: the future is bright

THERAPEUTIC ADVANCES IN GASTROINTESTINAL ENDOSCOPY. Bd. 12. 2019


Heesen, Ludwig; Frenzel, Katrin; Bolte, Stefanie et al.

Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)

CANCER RESEARCH. Bd. 79. H. 13. 2019


Sasca, Daniel; Szybinski, Jakub; Schueler, Andrea et al.

NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML

BLOOD. Bd. 133. H. 21. 2019 S. 2305-2319


Hasenburg, A.

Neoadjuvant Chemotherapy for Ovarian Cancer?

GYNAKOLOGE. Bd. 52. H. 9. 2019 S. 638-638